Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

A. Rillig, C. Magnussen, A.K. Ozga, A. Suling, A. Brandes, G. Breithardt, A.J. Camm, H.J.G.M. Crijns, L. Eckardt, A. Elvan, A. Goette, M. Gulizia, L. Haegeli, H. Heidbuchel, K.H. Kuck, A. Ng, L. Szumowski, I. van Gelder, K. Wegscheider, P. Kirchhof*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Web of Science)
Original languageEnglish
Pages (from-to)845-858
Number of pages14
JournalCirculation
Volume144
Issue number11
DOIs
Publication statusPublished - 14 Sep 2021

Keywords

  • CATHETER ABLATION
  • DAPA-HF
  • acute coronary syndrome
  • anti-arrhythmia agents
  • atrial fibrillation
  • atrial fibrillation ablation
  • controlled clinical trial
  • death
  • heart failure
  • stroke
  • ASSOCIATION

Cite this